Skip to main content
Clinical Trials/JPRN-UMIN000010276
JPRN-UMIN000010276
Recruiting
未知

The study of predictive factors for the effect of Salmeterol/Fluticasone combination(SFC) on the patients with obstructive pulmonary dysfunction. - Evaluation of Salmeterol/ Fluticasone propionate compound effecacy in chronic obstructive pulmonary disease.

Kagoshima university pulmonary medicine0 sites60 target enrollmentMarch 19, 2013

Overview

Phase
未知
Intervention
Not specified
Conditions
obstructive pulmonary dysfunction
Sponsor
Kagoshima university pulmonary medicine
Enrollment
60
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 19, 2013
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Kagoshima university pulmonary medicine

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) medication of corticosteroid in 4wks 2\) medication of anticholinergic drug in 4wks 3\) medication of long acting beta agonist in 4 wks 4\) inhalation of short acting beta agonist in 6hrs 5\) patients who has heart failure, severe arrhythmia. 6\) medication of beta blocker 7\) active infectious disease and tuberculous disease 8\) pationts who had resected lung 9\) psycosomatic patients 10\) allergy for SFC 11\) difficult to do spirometry 12\) pregnancy 13\) diagnosis for other pulmonary disease

Outcomes

Primary Outcomes

Not specified

Similar Trials